Biological applications of alkaloids derived from the tunicate E

Details Biological applications of alkaloids derived from the tunicate E Biological applications of alkaloids derived from the tunicate E

1993-03-09

1995-07-11

Richter, Johann

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

A61K 3154

Patent

active

054321727

ABSTRACT:
Biological applications of synthetic and natural alkaloids derived from the tunicate Eudistoma sp. are disclosed. A method regulating cell growth includes contacting one or more cells with an effective concentration of a compound for regulating cell growth. These compounds include: Segoline A, Segoline B, Isosegoline A, Norosegoline, Debromoshermilamine, Eilatin, 4-methylpyrido[2,3,4-kl]acridine, pyrido[2,3,4-kl]acridine, 1-acetyl-2,6-dimethylpyrido[2,3,4-kl]acridine, and derivatives and combinations of these compounds. An effective concentration range for using these compounds can range from approximately 0.1 .mu.M to 100 .mu.M. The effective concentration range for Eilatin, the most potent of these compounds is from 0.01 .mu.M to 0.99 .mu.M, and the effective concentration range for the other compounds of the present invention is from about 1.0 .mu.M to 100 .mu.M. The method has been shown to suppress growth of tumor cells, to induce differentiation of the tumor cells, and induce reverse transformation of the tumor cells. In transformed cells, the method induces reverse transformation. The method also inhibits the proliferation of cells. The examples show that the method of the present invention affects cyclic AMP mediated biological processes. At the effective concentrations this method affects the cyclic AMP mediated biological processes of cells to achieve the results described above.

REFERENCES:
patent: 4857538 (1989-08-01), Kashman et al.
patent: 5278168 (1994-01-01), Spector et al.
Kaul et al., Ann. Rev. Pharmacol., 26, 117-142 (1986).
Scheuer, Science, 248, 173-177 (1990).
Spector et al., Science, 214, 493-495 (1983).
Coue et al., FEBS Lett., 213, 316-318 (1987).
Spector et al., Cell Motility and the Cytoskeleton, 13, 127-4 (1989).
Rudi et al., Tet. Lett., 29, 6655-6656 (1988).
Rudi et al., Tet. Lett., 29, 3861-3862 (1988).
Rudi et al., J. Org. Chem., 54, 5331-5337 (1989).
Schmitz et al., J. Am. Chem. Soc., 105, 4835-4837 (1983).
Bloor et al., J. Am. Chem. Soc., 109, 6134-6136 (1987).
Cooray et al., J. Org. Chem., 53, 4619-4620 (1988).
Kobayashi et al., J. Org. Chem., 53, 1800-1804 (1988).
Kobayashi et al., Tet. Lett., 29, 1177-1180 (1988).
Charyulu et al., Tet. Lett., 30, 4201-4202 (1989).
Molinski et al., J. Org. Chem., 54, 4256-4259 (1989).
Schmitz et al., J. Org. Chem., 56, 804-808 (1991).
Lockwood et al., J. Cell. Biochem., 33, 237-255 (1987).
Willingham, Int. Rev. Cytol., 44, 319-363 (1976).
Schubert, Developmental Biology of Cultured Nerve, Muscle, and Gila, John Wiley & Sons, New York (1984).
Katsaros et al., FEBS Lett., 223, 97-103 (1987).
Tagliaferri et al., Cancer Res., 48, 1642-1650 (1988).
Tortora et al., Proc. Natl. Acad. Sci. USA, 87, 705-708 (1990).
Pilkis et al., Annu. Rev. Nutr., 11, 465-515 (1991).
Maghrabi et al., J. Biol. Chem., 257, 233 (1982).
Hod et al., J. Biol. Chem., 259, 15603-15608 (1984).
Granner et al., J. Biol. Chem., 265, 10173-10176 (1990).
Bilezikjian et al., Endocrinology, 113, 1726-1731 (1983).
Ray et al., Mol. Cell. Endocrinology, 45, 175-182 (1986).
Gabriel et al., Neuroendocrinology, 50, 170-176 (1989).
Carroll et al., J. Org. Chem., 54, 4231-4232 (1989).
Amano et al., Proc. Natl. Acad. Sci. USA, 63, 258-263 (1972).
Spector, "Electrophysiology of clonal nerve cell lines", in: Excitable Cells in Tissue Culture, Nelson et al., eds., Plenum, N.Y., 247-277 (1981).
Hynes et al., Cell, 13, 151-163 (1978).
Hod et al., N.Y. Acad. Sci., 478, 31-45 (1986).
Hod et al., J. Biol. Chem., 263, 7747-7752 (1988).
Vine et al., Red Sea Invertebrates, Ch. 10, 209-210, Immel Publishing (1986).
Rinehart, Jr., et al., J. Am. Chem. Soc., 109, 3378-3387 (1987).
Rinehart, Jr., et al., Pure & Appl. Chem., 53, 795-817 (1981).
Schmitz et al., J. Am. Chem. Soc., 105, 4835-4836 (1983).
Carroll et al., J. Org. Chem., 55, 4426-4431 (1990).
Gellerman et al., Tet. Lett., 33, 5577-5580 (1992).
Ali et al., J. Chem. Soc., Chem. Commun., 1453-1454 (1992).
Partridge et al., J. Chem. Soc. (C), 632-635 (1962).
Tindale et al., Aust. J. Chem., 37, 611-617 (1984).
Schafer et al., Angew. Chem. (Int. Ed.), 10, 405-406 (1971).
Schafer et al., Angew. Chem. (Int. Ed.), 10, 406-407 (1971).
Moody et al., Tetrahedron, 48, 3589-3602 (1992).
He et al., J. Org. Chem., 56, 5369-5371 (1991).
Gellerman et al., Tet. Lett., 34, 1823-1826 (1993).
Gellerman et al., Tet. Lett., 34, 1827-1830 (1993).

Affiliated with

Also associated with

Rating

Biological applications of alkaloids derived from the tunicate E does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Biological applications of alkaloids derived from the tunicate E, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biological applications of alkaloids derived from the tunicate E will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-503579